Skip to main content
GENFLOW BIOSCIENCES PLC logo

GENFLOW BIOSCIENCES PLC — Investor Relations & Filings

Ticker · GENF ISIN · GB00BP2C3V08 LEI · 213800HVOFXRXVEGDN62 IL Professional, scientific and technical activities
Open in API
Filings indexed 142 across all filing types
Latest filing 2022-06-14 AGM Information
Country GB United Kingdom
Listing IL GENF

About GENFLOW BIOSCIENCES PLC

https://genflowbio.com/

Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.

Recent filings

Filing Released Lang Actions
Results of AGM
AGM Information Classification · 99% confidence The document explicitly states in the title and body: 'Results of Annual General Meeting'. It confirms that 'all resolutions proposed at the Annual General Meeting held earlier today were duly passed.' This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the results thereof. Although it is a results announcement, the core subject matter is the AGM outcome, making AGM-R the most specific fit over a general Regulatory Filing (RNS). The document length is short (3192 chars), but it is reporting the definitive results, not just announcing that a report is available.
2022-06-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1934 characters) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, referencing the RNS Number and the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA). This type of brief, time-sensitive market operational update that doesn't fit into standard financial reporting categories (like 10-K, ER, or IR) is best classified as a general regulatory announcement or filing. Since it is a direct notification via the RNS system about a trading mechanism event, the most appropriate category is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous regulatory announcements.
2022-05-26 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1917 characters) and announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange, referencing 'RNS Number : 9842M' and stating that RNS is the news service approved by the Financial Conduct Authority (FCA). This is a routine, brief regulatory announcement that does not fit the definitions for specific financial reports (like 10-K, ER, IR) or corporate actions (like DIV, CAP). Since it is a general regulatory announcement provided via the RNS system and doesn't fit a more specific category, the appropriate classification is the general regulatory fallback.
2022-05-26 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 99% confidence The document is very short (1934 characters) and is titled 'Second Price Monitoring Extension' under the RNS Number system. It describes an extension of an auction call period due to price volatility, which is a specific operational announcement related to trading on the London Stock Exchange. This type of short, specific regulatory operational notice that doesn't fit into standard financial reporting categories (like 10-K, ER, or IR) is best classified under the general regulatory announcement category, RNS (Regulatory Filings), as per the provided definitions and the 'MENU VS MEAL' rule suggesting short announcements default to RPA or RNS.
2022-05-26 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1917 characters) and its primary content is an announcement titled 'Price Monitoring Extension' issued via 'RNS Number : 9671M' by Genflow Biosciences PLC. It describes an extension of the auction call period on the London Stock Exchange due to price monitoring rules. The text explicitly mentions RNS as the news service approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. This structure—a brief, time-sensitive operational update disseminated through the official regulatory news service—fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K, IR, ER) nor a specific corporate action (like DIV, DIRS, CAP). It is a general regulatory announcement.
2022-05-26 English
Second Price Monitoring Extn
Legal Proceedings Report Classification · 99% confidence The document is very short (1934 characters) and begins with 'RNS Number'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a specific, time-sensitive operational announcement related to market mechanics rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement provided by RNS (the news service of the London Stock Exchange) and does not fit into the more specific categories like DIRS, DIV, or ER, it falls best under the general regulatory announcement category.
2022-05-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.